Medical Device | March 07, 2022
Thermo Fisher Scientific unveils new genetic analyzer
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
The CO2 Optimization module is one of the four modules (Product Costing, BoM Management, CO2 Optimization, Supplier Strategy) within the entire NDC Simulation Suite
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations
This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant
Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Subscribe To Our Newsletter & Stay Updated
